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Chromatin is pivotal for regulation of the DNA damage process
insofar as it influences access to DNA and serves as a DNA repair
docking site. Recent works identify histone chaperones as key re-
gulators of damaged chromatin’s transcriptional activity. However,
understanding how chaperones are modulated during DNA damage
response is still challenging. This study reveals that the histone chap-
erone SET/TAF-Iβ interacts with cytochrome c following DNA damage.
Specifically, cytochrome c is shown to be translocated into cell nuclei
upon induction of DNA damage, but not upon stimulation of the
death receptor or stress-induced pathways. Cytochrome c was found
to competitively hinder binding of SET/TAF-Iβ to core histones,
thereby locking its histone-binding domains and inhibiting its nucle-
osome assembly activity. In addition, we have used NMR spectros-
copy, calorimetry, mutagenesis, and molecular docking to provide an
insight into the structural features of the formation of the complex
between cytochrome c and SET/TAF-Iβ. Overall, these findings estab-
lish a framework for understanding the molecular basis of cyto-
chrome c-mediated blocking of SET/TAF-Iβ, which subsequently may
facilitate the development of new drugs to silence the oncogenic
effect of SET/TAF-Iβ’s histone chaperone activity.
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The oncoprotein SET/template-activating factor (TAF)-Iβ(SET/TAF-Iβ)—also known as inhibitor-2 of protein phos-
phatase-2A (I2PP2A) and inhibitor of histone acetyltransferase
(INHAT)—belongs to the nucleosome assembly protein (NAP)
family of histone chaperones. SET/TAF-Iβ participates in nu-
merous cellular processes, including cell cycle control (1), apo-
ptosis (2), transcription regulation (3), and chromatin remodelling
(4). Many recent studies highlight the chromatin-related proper-
ties of SET/TAF-Iβ. As a histone chaperone, SET/TAF-Iβ asso-
ciates to core histones to shield their positive charge, preventing
improper contact with DNA and facilitating the correct deposition
of free histones onto DNA for nucleosome formation (5). Recent
work points to the crucial role of chromatin dynamics in DNA
damage response (6–8). In fact, histone chaperones have emerged
as key players in the transient disorganization of chromatin re-
quired in the DNA repair process. Thus, the histone chaperones
aprataxin-PNK–like factor (APLF) (6), antisilencing function
1 (Asf1) (9), chromatin assembly factor 1 (CAF-1) (10), death
domain-associated protein 6 (DAXX) (11), facilitating chromatin
transcription (FACT) (12), histone regulator A (HIRA) (13),
nucleolin (14), p400 (15), and nucleosome assembly protein 1-like
1 (NAP1L1) and 1-like 4 (NAP1L4) (7) are recruited to damaged
chromatin, thereby promoting histone dynamics in response to
DNA damage. Recently, SET/TAF-1β was found to be recruited
to DNA breaks to modulate the DNA damage response through
the retention of certain chromatin proteins, resulting in chromatin
compaction (16). We have identified SET/TAF-Iβ as a target
protein for cytochrome c (Cc) following the release of the latter
from mitochondria in human cells treated with apoptotic agents
(17, 18). Although the hemeprotein Cc serves as an electron carrier
between complexes III and IV in the mitochondrial respiratory
chain, its role in nuclei has yet to be convincingly elucidated. It has
been proposed, however, that Cc accumulation in the nucleus
under apoptotic stimuli relates to nuclear pyknosis, DNA frag-
mentation (19), and chromatin remodelling (20). Here, we show
that the SET/TAF-Iβ oncoprotein interacts with Cc in the cell
nucleus in response to treatment of the cell with different well-
known inducers of DNA damage and apoptosis, but not to treat-
ment with other apoptosis-inducing agents. We also demonstrate
that Cc impairs the histone chaperone activity of SET/TAF-Iβ
through competitive binding, thereby preventing the formation of
core histone–SET/TAF-Iβ complexes.
Results
Cc Interacts with SET/TAF-Iβ in the Nucleus Following DNA Damage.
DNA damage can be induced by ionizing radiation or top-
oisomerase inhibitors (e.g., CPT). Subcellular localization of Cc in
Heltog cells—a HeLa cell line constitutively expressing green
fluorescent protein (GFP)-tagged Cc—showed Cc-GFP pre-
dominantly in mitochondria of untreated cells (Fig. 1A, Left).
Confocal analysis of cells treated with 20 μMCPT for 4 h revealed
a translocation of Cc-GFP from mitochondria to the cytoplasm
and the nucleus. The nuclear localization of Cc-GFP has been
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confirmed by colocalization with the Hoechst staining (Fig. 1A,
Right). Subcellular fractionation of Heltog cells treated with 20 μM
CPT showed endogenous Cc accumulation in the cell nucleus after
4 h (Fig. 1B). In fact, Cc appeared in the nucleus after 1 h treat-
ment, as previously observed in HeLa cells treated with either UV
irradiation or CPT (20). Codetection in the nuclear cell fraction
with nuclear-specific poly (ADP ribose) polymerase (PARP) con-
firmed the Cc translocation into the nucleus (Fig. 1B). Notably,
following treatment with CPT, Cc translocation into the nucleus
occurs before caspase-3 activation (Fig. 1D). To further demonstrate
the relationship between endogenous SET/TAF-Iβ and Cc in
response to DNA damage, in-cell interaction between them was
examined using immunoprecipitation (IP). An antibody against
Cc was used to extract associated proteins in nuclear lysates of
Heltog cells treated with 20 μM CPT for 4 h. As shown in Fig.
1C, Upper, SET/TAF-Iβ coimmunoprecipitated with endogenous
Cc after CPT treatment (lane 5), whereas untreated cells (con-
trol) did not show any band corresponding to SET/TAF-Iβ
(lane 2). To confirm the IP specificity, nuclear lysates from un-
treated and CPT-treated cells were probed with the SET/TAF-Iβ
antibody (Fig. 1C, Upper, lanes 1 and 4, respectively), whereas
the negative controls (Fig. 1C, Upper, lanes 3 and 6) did not show
any band when IgG was used. Cc IP was confirmed by immu-
noblotting with the anti-Cc antibody (Fig. 1C, Upper). To con-
firm our findings, a reverse IP using the SET/TAF-Iβ antibody
was performed, and endogenous Cc was then pulled down (Fig.
1C, Lower). To examine whether the observed Cc:SET/TAF-Iβ
interaction is restricted to cells experiencing DNA damage, the
effect of tumor necrosis factor (TNF)-related apoptosis-inducing
ligand (TRAIL) and staurosporine (STP)—two well-known ap-
optosis-inducing agents for which DNA damage is not an in-
itiating event—was studied. TRAIL is a member of the TNF
superfamily that can induce cell death either by the extrinsic
pathway or by the BH3 interacting-domain death agonist (Bid)-
mediated mitochondrial pathway (21). STP is a broad-spectrum
protein kinase inhibitor that promotes intracellular stress-in-
duced apoptosis (22). Apoptosis induction with TRAIL or STP
may result in DNA damage in later stages of treatment. There-
fore, cell cultures were first tested to determine whether they
exhibited DNA damage following TRAIL- or STP-induced ap-
optosis. To this end, Heltog cell lysates were treated with 100 ng/mL
TRAIL or 1 μMSTP for 1, 2, 4, and 8 h and immunoblotted against
Ser139-phosphorylated histone H2AX (γ-H2AX). γ-H2AX is an
extremely sensitive marker of DNA damage as it accumulates
Fig. 1. CPT-induced nuclear translocation of Cc and
formation of the Cc:SET/TAF-Iβ complex. (A) Sub-
cellular localization of Cc-GFP stably expressed (green;
Upper) in Heltog cells upon treatment with 20 μM
CPT for 4 h detected by confocal microscopy (60x oil
objective). Nuclei were stained in blue with Hoechst.
Colocalization of green Cc-GFP fluorescence and blue
nuclear staining is shown in the merge images
(Lower). (Scale bars, 25 μm.) (B) Subcellular fraction-
ing showing endogenous Cc location upon treatment
with 20 μM CPT for 1 or 4 h. Nontreated and CPT-
treated Heltog cells were fractionated to yield cyto-
solic, membrane/organelle (Memb./Org.) and nuclear
fractions. Purity of subcellular fractions was verified
by Western blot using anti–α-Tub (50 kDa), anti-Cox
IV (17 kDa), and anti-PARP (116 kDa) antibodies. (C,
Upper) IP of SET/TAF-Iβ with endogenous Cc after
treating Heltog cells with 20 μM CPT for 4 h. Western
blot showed the detection of SET/TAF-Iβ as an ∼34-
kDa band (lanes 1 and 4) in the nuclear fraction. Cc-IP
of nuclear lysates from nontreated (lane 2) and CPT-
treated cells (lane 5), followed by probing with the
SET/TAF-Iβ antibody. Confirmation of immunopreci-
pitated Cc from nuclear lysates is also shown (lanes 4
and 5) under CPT treatment. (Lower) Reverse IP of
endogenous Cc with SET/TAF-Iβ following CPT treat-
ment. Detection of Cc as an ∼12-kDa band in the
nuclear lysate (lane 4) and in the IP of SET/TAF-Iβ of
CPT-treated cells (lane 5). Mouse IgG was used as
control (lanes 3 and 6). (D) Detection of caspase-3
activation in Heltog cells treated with 20 μM CPT for
1, 4, and 24 h and 100 ng/mL TRAIL for 2 h. Cleaved
caspase-3 (19 and 17 kDa) and full-length (116 kDa) or
cleaved PARP (89 kDa) was detected by Western blot.
Procaspase-3 (32 kDa) and α-Tub (50 kDa) antibodies
were used as controls. (E) DNA-damage response upon
treatment of Heltog cell cultures with 100 ng/mL TRAIL
and 1 μM STP or 20 μM CPT for 0, 1, 2, 4, and 8 h.
Specific antibody against phosphorylated γ-H2AX was
used in Western blotting. α-Tub antibody was used as
loading control. (F) Subcellular fractioning showing en-
dogenous Cc location upon treatment with 100 ng/mL
TRAIL for 2 h or 1 μM STP for 4 h.
























rapidly in response to double-strand breaks (DSBs). As shown, the
DNA-damage–dependent accumulation of γ-H2AX occurs after 4
or 8 h of treatment with TRAIL and STP, respectively (Fig. 1E). By
contrast, CPT promotes histone H2AX phosphorylation after 1 h.
Because no significant DNA damage was observed following ex-
posure to TRAIL for 2 h or STP for 4 h, these exposure times were
selected to further explore Cc localization. Consequently, following
the exposure of Heltog cell cultures to 100 ng/mL TRAIL for 2 h or
1 μM STP for 4 h, subcellular fractionation was applied, indicating
Cc as having been translocated from mitochondria to cytosol, but
not to the nucleus (Fig. 1F). This corresponds to findings in pre-
vious studies of Cc release from mitochondria in response to
TRAIL and STP (23, 24). Nevertheless, our study shows endoge-
nous Cc as having been unable to reach the cell nucleus following
treatments with TRAIL or STP (Fig. 1F). This contrasts with the
presence of Cc in the nucleus observed in response to CPT-induced
DNA damage (Fig. 1 A and B). The translocation of Cc into the
nucleus, along with the former’s interaction with SET/TAF-Iβ, has
been studied following the induction of DNA damage with indo-
tecan, a noncamptothecin inhibitor of topoisomerase I (25), and
doxorubicin, a topoisomerase II inhibitor (26) (SI Appendix, Fig.
S1). Altogether, these results indicate that a specific DNA-damage
stimulus triggers nuclear translocation of Cc, thereby permitting
binding to its nuclear target SET/TAF-Iβ.
Cc Binds to SET-TAF-Iβ and Blocks Histone Binding. To explore the
biological significance of the Cc:SET/TAF-Iβ interaction in re-
sponse to a DNA-damage stimulus, we tested the ability of Cc to
prevent histone binding to SET/TAF-Iβ. Hence, an electrophoretic
mobility shift assay (EMSA) was performed to detect complex
formation between SET/TAF-Iβ and calf-thymus histones and to
further study the effect of the addition of Cc. The mobility of the
histone mixture, as well as Cc and SET/TAF-Iβ, are shown in Fig.
2A (lanes 1–3). Due to their opposite charges, Cc and SET/TAF-Iβ
migrated in reverse directions. Notably, the histone mixture vaguely
penetrated the gel in the EMSA assay due to its propensity to form
large aggregates (SI Appendix, Fig. S2A). The lower mobility of
SET/TAF-Iβ following histone addition (Fig. 2A, lane 4) indicates
the formation of chaperone–histone complexes. The addition of Cc
at increasing concentrations to the SET/TAF-Iβ and histone mix-
ture (Fig. 2A, lanes 5–14) made the chaperone mobility match
observed for the Cc:SET/TAF-Iβ complex (lane 15), revealing that
Cc competes with histones for the SET/TAF-Iβ binding site. To
confirm the EMSA results, NMR measurements of reduced Cc
were recorded in the presence of SET/TAF-Iβ and Xenopus laevis
core histones H2B, H3, and H4. The use of isolated histones
allowed for a comparison of their respective binding affinities for
the chaperone in competition with Cc. However, binding to histone
H2A could not be tested, as the expression of H2A was not pos-
sible. Specifically, the Met80-eCH3 NMR signal of the methionine
axial ligand of Cc (Met80) was monitored. As shown, this signal
broadens beyond the detection limit upon the addition of SET/
TAF-Iβ (Fig. 2B). This is due to the long diffusional correlation
time of Cc bound to SET/TAF-Iβ, which results in a fast signal
relaxation. As expected for a binding competition, titration of the
Cc:SET/TAF-Iβ solution with increasing concentrations of H2B,
H3, or H4 histones led to dissociation of Cc from SET/TAF-Iβ and
the recovery of the Met80-eCH3 signal. As a control, BSA was
added to unbound Cc at the same ratio as that used for SET/TAF-Iβ.
The line width of Met80-eCH3 of the Cc remained unchanged as
unbound Cc, suggesting that Cc does not interact with BSA (Fig. 2C).
To avoid nonspecific interactions, 1D 1H NMR spectra of Cc,
following binding to SET/TAF-Iβ and a calf-thymus histone
mixture in the presence of 100 mM KCl, were recorded (SI
Appendix, Fig. S2B). The same competition effect was observed
as that shown in Fig. 2B: namely, titration with increasing con-
centrations of histones led to the dissociation of Cc from SET/
TAF-Iβ and the recovery of the intensity of the Met80-eCH3 Cc
signal. Circular dichroism (CD) spectra of SET/TAF-Iβ and
histones H2B, H3, and H4 corroborated the proper secondary
structure organization (SI Appendix, Fig. S2C). To compare the
binding thermodynamics of the complexes formed by SET/TAF-Iβ
with Cc and core histones, Isothermal Titration Calorimetry (ITC)
experiments were performed. Measurements revealed the in-
teraction between Cc and SET/TAF-Iβ being slightly exothermic
and entropically driven (binding enthalpy, ΔH, −0.9 kcal·mol−1)
with a dissociation constant (KD) of 3.1 μM and a Cc:SET/TAF-Iβ
stoichiometry of 2:1 at 25 °C (SI Appendix, Table S1). Notably, the
binding of Cc to SET/TAF-Iβ exhibited weak positive cooperativity
(SI Appendix, Fig. S3), yielding a cooperativity constant (k) of 3.8
and leading to a smaller KD value and a very positive enthalpy of
interaction for the second site (SI Appendix, Table S1). In other
words, the binding of the first Cc molecule increases 3.8 times the
affinity for the binding of a second Cc molecule to SET/TAF-Iβ.
Therefore, it might be plausible that, following the binding of the
first Cc molecule, SET/TAF-Iβ undergoes a conformational change
that facilitates the interaction with the second Cc molecule. As be-
fore, ITC experiments were used to quantitatively assess the binding
of SET/TAF-Iβ to the core histones H2B, H3, and H4 from X. laevis.
As shown (SI Appendix, Fig. S3 and Table S1), H3 binds SET/TAF-
Iβ with a lower affinity (KD = 25 μM) than H2B (KD = 2 μM) or H4
(KD = 6 μM). These values agree with those previously reported for
the interaction of SET/TAF-Iβ with H2B (KD = 2.87 μM), but differ
slightly for H3 (KD = 0.15 μM) (27). In all cases, the stoichiometry of
histone:SET/TAF-Iβ interactions was 2:1 (SI Appendix, Table S1).
Fig. 2. Competition between histones and Cc for binding to SET/TAF-Iβ.
(A) EMSA showing competitive interaction of SET/TAF-Iβwith calf-thymus histones
in the presence of Cc at increasing concentrations. (B) 1D 1H NMR spectra
monitoring Met-80 methyl signal of reduced Cc in the presence of SET/TAF-Iβ
and X. laevis core histones. Details of superimposed 1D 1H NMR spectra of
13 μM reduced Cc [either free (black) or bound to 3.5 μMSET/TAF-Iβ (pink)] in the
presence of the X. laevis core histones H2B, H3, or H4 at increasing concen-
trations of 5 μg (cyan), 10 μg (orange), 20 μg (green), 30 μg (blue), and 40 μg
(red). (C, Left) 1D 1H NMR spectra monitoring Met-80 methyl signal of 13 μM
reduced Cc in the presence (dashed line) and absence (straight line) of 3.5 μM
BSA. (Right) SDS/PAGE showing the Cc and BSAmixture used in the 1D 1H NMR
spectrum (lane 3). Isolated Cc (lane 1) and BSA (lane 2) are shown as controls.
(D) Impairment of the histone chaperone activity of SET/TAF-Iβ by Cc. Two
micrograms SET/TAF-Iβ was combined with 200 ng relaxed plasmid after being
treated with Topo I and incubated with 2 μg HeLa core histones. Nucleosome
assembly activity was tested in the absence (lane 3) and the presence of Cc at
increasing concentrations (lanes 4–6). Relaxed and supercoiled forms of circular
plasmid DNA are indicated by “R” and “S,” respectively. Lane 2 corresponds to
DNA plasmid relaxed after treatment with Topo I, whereas lane 1 (control)
shows a supercoiled, untreated DNA plasmid. The arrow indicates the top-
oisomer with a high number of nucleosomes.
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As for NMR titrations, ITC measurements at 100 mM KCl were
also recorded to suppress nonspecific interactions (SI Appendix,
Table S1). At high ionic strength, the binding affinity of the two-
component complexes decreases because all are electrostatically
driven and their stoichiometry remains unaltered.
SET/TAF-Iβ Histone-Binding Domain Is Engaged During Binding to Cc.
Considering that Cc binds to SET/TAF-Iβ and affects its interaction
with core histones, we aimed at determining whether Cc recognizes
the SET/TAF-Iβ histone-binding domain. SET/TAF-Iβ forms a
headphone-shaped homodimer, each monomer consisting of an N
terminus, a backbone helix, an “earmuff” domain, and an acidic
disordered stretch (5) (SI Appendix, Fig. S4). The region of SET/
TAF-Iβ responsible for histone binding, and chaperone activity
comprises the lower area of the so-called “earmuff” domain (5). To
examine the SET/TAF-Iβ region involved in binding to Cc, two
different SET/TAF-Iβ deletion mutants were designed. The first
included the N terminus along with the backbone helix [hereafter
referred to as SET/TAF-Iβ(1–80) (amino acids 1–80)], whereas the
second [SET/TAF-Iβ(81–277) (amino acids 81–277)] encoded the
“earmuff” domain and the acidic stretch of the C terminus. Worth
particular mention is that CD spectra of both mutants indicated a
secondary structure similar to that of the wild-type protein (SI
Appendix, Fig. S2C). ITC of Cc interactions with SET/TAF-Iβ(1–80)
and SET/TAF-Iβ(81–277) showed the binding reaction in both cases
(SI Appendix, Fig. S5, Upper). However, weak calorimetric signals in
the thermogram of SET/TAF-Iβ(1-80) throughout the titration with
Cc (SI Appendix, Fig. S5, Upper) suggest a weak interaction with an
estimated KD of 44 μM (SI Appendix, Table S1). On the contrary,
the affinity between Cc and SET/TAF-Iβ(81–277) was higher and
yielded a KD of 9.6 μM. The results indicate a binding preference of
Cc for the C terminus of SET/TAF-Iβ and explain the way in which
Cc hampers the chaperone’s ability to bind to histones. To further
confirm the C terminus of SET/TAF-Iβ as the region interacting
with Cc, two SET/TAF-Iβ mutants were obtained by replacing three
adjacent amino acid residues from the “earmuff” domain by alanine
residues (SI Appendix, Fig. S4). Mutants S162A/K164A/D165A and
T191A/T194A/D195A (SI Appendix, Fig. S4, green and red, re-
spectively) failed to bind to histones and demonstrated significantly
reduced histone chaperone activity (35% of wild-type activity) (5).
According to the calorimetric data resulting from the titrations of
the two SET/TAF-Iβ triple mutants with Cc (SI Appendix, Fig. S5,
Lower), the S162A/K164A/D165A mutant shows a higher affinity
toward Cc (KD= 6.3 μM) than T191A/T194A/D195A (KD= 22 μM).
These findings suggest that threonine residues at positions 191 and
194 and aspartate at 195, located in the lower region of the “earmuff”
domain, are involved in the interaction with Cc, as they are in the
histone remodelling activity of SET/TAF-Iβ.
SET/TAF-Iβ Histone Chaperone Activity Is Impaired by Cc. As binding
to core histones is essential for the histone chaperone activity of
SET/TAF-Iβ, the ability (or inability) of Cc to affect such activity
was tested using a supercoiling assay (SI Appendix, Fig. S6A).
The histone chaperone activity of SET/TAF-Iβ has been pre-
viously demonstrated by the same supercoiling assay used here
(5). SET/TAF-Iβ assembled nucleosomes onto the plasmid, re-
sulting in enhanced supercoiling and subsequently increased
electrophoretic migration compared with the relaxed DNA (com-
pare lanes 2 and 3 of Fig. 2D). Although highly supercoiled DNA
migrated in a single band, many different topoisomers might be
present (Fig. 2D). The slight lower band that runs faster in the
plasmid incubated with SET/TAF-Iβ and core histones (lane 3, Fig.
2D) corresponded to a topoisomer with a high number of assem-
bled nucleosomes due to an increase in supercoiling. Although the
relaxed band did not disappear following the addition of 0.5 or 1 μg
Cc (lanes 4 and 5 of Fig. 2D), the topoisomers (the bands that run
faster due to supercoiling) decreased in intensity, indicating a de-
crease in the amount of plasmid supercoiling. These facts reveal an
inhibition of the chaperone activity of SET/TAF-Iβ when mediated
by Cc. Controls corresponding to the supercoiling assay are also
shown (SI Appendix, Fig. S6B).
Cc Heme Crevice Faces SET/TAF-Iβ Upon Binding. To dig into the
structural features of the interaction between Cc and SET/TAF-Iβ,
the Cc:SET/TAF-Iβ interaction was monitored by recording [1H, 15N]
Heteronuclear Single-Quantum Correlation (HSQC) spectra of fully
reduced 15N-labeled Cc, which was either free or bound to unlabeled
SET/TAF-Iβ. Titration of SET/TAF-Iβ onto 15N Cc resulted in a
significant broadening of the Cc resonances, thereby suggesting the
formation of the Cc:SET/TAF-Iβ complex (Fig. 3A). Additionally,
specific resonances from residues at the complex interface may show
enhanced broadening. Consequently, the line widths (ΔΔν1/2Binding)
of 15N-labeled Cc resonances were analyzed in a pure Cc sample and
a 1:0.25 Cc:SET/TAF-Iβ mixture . Signals showing this effect corre-
sponded to Thr19, Lys39, Gly41, Gln42, Tyr48, Lys79, Ile81, Ala92,
and Leu94 in the 15N dimension (SI Appendix, Fig. S7A). Hence,
these residues can be expected to be at or near the region of Cc
interacting with SET/TAF-Iβ. In addition to specific line broadening,
several amide resonances in the [1H, 15N] HSQC spectra of Cc ex-
hibit chemical-shift perturbations (CSPs) in the presence of SET/
TAF-Iβ (Fig. 3A). For example, the details of the superimposed
spectra (SI Appendix, Fig. S7B) show that Ala50 and Glu89 reso-
nances shift gradually at increasing Cc:SET/TAF-Iβ ratios (1:0.06,
1:0.12, and 1:0.25). These CSPs indicate that these residues experi-
enced a change in their chemical environment in the presence of
SET/TAF-Iβ. Therefore, they may belong to the complex interface.
To identify the residues involved in the complex interface, an average
CSP analysis (ΔδAvg) of the Cc amide signals was obtained. 15N Cc
resonances from Gln16, Gly77, Val83, Lys88, Glu89, and Asp93
Fig. 3. NMR titrations of 15N-labeled reduced Cc with SET/TAF-Iβ. (A) Super-
imposed [1H-15N] 2D HSQC spectra of 15N-labeled Cc, which is either free or
bound to dimeric SET/TAF-Iβ at Cc:SET/TAF-Iβ molar ratio of 1:0.25. (B) Mapping
of Cc residues perturbed upon binding to SET/TAF-Iβ. Cc surfaces are rotated 180°
around vertical axes in each view. Residues are colored according to their ΔδAvg
(ppm):≥0.075 (red), between 0.075 and 0.050 (orange), between 0.050 and 0.025
(yellow), and < 0.025 (blue). Unassigned and Pro residues are in gray, whereas
the heme group is in green.
























experience significant chemical shifts (ΔδAvg ≥ 0.075) following
binding to SET/TAF-Iβ (SI Appendix, Fig. S7C). Strikingly, the ma-
jority of perturbed Cc residues are located on the side of the exposed
heme periphery (Fig. 3B). Notably, a similar surface patch of Cc is
involved in the interactions with cytochrome c oxidase (28) and cy-
tochrome bc1 (29). Interestingly, the interaction between Cc and the
SET/TAF-Iβ chaperone implicated 10 lysine residues—namely 5, 7,
8, 22, 25, 53, 72, 73, 86, and 88 (Fig. 3B)—thereby evidencing the
key role of electrostatic forces in the formation of Cc:SET/TAF-Iβ
complexes. Similarly, lysine residues are also involved in the in-
teraction with cytochrome bc1 (29, 30). Given the well-known “ly-
sine masking activity” of SET/TAF-Iβ that prevents the acetylation
of histone lysines inside the INHAT complex (3), it is plausible that
SET/TAF-Iβ also recognizes the lysine residues from Cc. In-
triguingly, the Cc residues thought to play an important role in the
interaction between the hemeprotein and apoptosis protease-acti-
vating factor-1 (Apaf-1)—namely, Lys7, Lys25, Lys39, and Lys72
(31)—perfectly match those identified in this study as interacting
with SET/TAF-Iβ. Furthermore, whereas studies of the complex
formed between Cc and prosurvival protein Bcl-xL identified both
His26 and Gly41 as the most important Cc residues affected upon
binding (32), the present study shows a change only in Gly41 fol-
lowing the addition of SET/TAF-Iβ to the Cc sample. To clarify the
role of the redox state of Cc, this interaction was also analyzed using
the oxidized form of Cc by combining NMR and ITC techniques.
Most of the residues of oxidized Cc involved in the binding to SET/
TAF-Iβ were the same as those found for its reduced form (SI
Appendix, Fig. S8A). Notably, specific Cc resonances were not de-
tectable upon complex formation as they broadened beyond the
detection limit (SI Appendix, Fig. S8A). Similarly, the ITC titration
using oxidized Cc resulted in similar thermogram profiles and
binding affinities as those of the reduced Cc (SI Appendix, Fig. S8B).
Altogether, this indicates that the redox state of Cc does not in-
fluence its binding to its nuclear target SET/TAF-Iβ.
Structural Look into the Cc:SET/TAF-Iβ Complex and NMR-Based
Molecular Docking Models. With the aim of defining Cc:SET/
TAF-Iβ complex interface regions, NMR restraint-driven docking
was performed. CSPs obtained from NMR analysis of the Cc:SET/
TAF-Iβ complex at a 1:0.25 ratio were used as input data. From
the 500 solutions obtained from the NMR-based docking (SI
Appendix, Fig. S9A), Cc geometric centers are represented around
Robertson (ribbon) diagrams of SET/TAF-Iβ. In agreement with
the two binding sites observed by ITC titrations, the models pre-
dicted by the NMR restraint-driven docking yielded two differ-
entiated clusters. One of these clusters included the vast majority
of highest scoring models (SI Appendix, Fig. S9A, cluster 1),
whereas the second cluster encompassed fewer than 50 solutions
(SI Appendix, Fig. S9A, cluster 2). Interestingly, nearly all of the
probe solutions are located in the same region of SET/TAF-Iβ—
namely, between its “earmuff” domains. This finding supports the
data reported in earlier sections of this study suggesting a
Cc-binding preference for the SET/TAF-Iβ histone-binding do-
main. Indeed, the highest-scoring solution from the first cluster
revealed how Cc leans its heme group to approach the lower region
of a SET/TAF-Iβ “earmuff” domain (SI Appendix, Fig. S9B). The
surface representation of both proteins shows them to be in close
contact. A secondary set of Cc structures with higher energies (cluster
2) was found near the backbone helices (SI Appendix, Fig. S9C).
Discussion
Inefficient repair of DNA lesions results in genome instability,
which can, in turn, lead to premature aging and cancer (33).
Chromatin dynamics regulate transcriptional activity in response
to DNA damage by promoting accessibility to DNA and serving
as a docking site for repair and signaling proteins, thereby in-
creasing repair efficiency (8, 34). Recent works reveal how his-
tone chaperones temporarily evict histones from a damaged site
to facilitate access of repair factors to DNA lesions (9). How-
ever, once a DNA break is repaired, histone chaperones return
histone proteins to the repaired site (35) and promote the re-
covery of transcriptional activity (7, 13). The data presented in
this study show the histone chaperone and oncoprotein SET/
TAF-Iβ to specifically interact with Cc in cell nuclei in response
to CPT-induced DNA damage. Although translocation of Cc to
the nucleus had previously been observed (19, 20), the specific
role of Cc in the nucleus has yet to be fully elucidated. However,
this work shows that Cc translocates into the cell nucleus in re-
sponse to DNA damage, but not following the TRAIL-activated
extrinsic pathway or STP-triggered stress-induced apoptosis. The
present study demonstrates that nuclear translocation of Cc oc-
curs early in the DNA damage response—just 1 h after treat-
ment. The finding suggests that Cc might be imported into the
nucleus by diffusion through the nuclear pore complex, although
the precise molecular mechanism is as yet unknown. As neither
TRAIL nor STP trigger Cc entry into the cell nucleus, the in-
teraction between Cc and SET/TAF-Iβ seems to be specifically
linked to DNA damage. CPT selectively targets the essential
mammalian enzyme Topo I in nuclei (36). CPT binds covalently
to Topo I and supercoiled DNA, thereby forming a ternary
complex that inhibits DNA religation and generates a greater
number of DSBs (37). Recently, it has been proposed that his-
tone chaperones play a central role in chromatin disassembly
connected with DNA repair and transcription recovery following
DNA damage (7, 9, 13, 35). Thus, histone chaperones such as
HIRA (13), FACT (12), nucleolin (14), APLF (6) Asf1 (9),
CAF-1 (10), DAXX (11), p400 (15), NAP1L1, and NAP1L4 (7)
actively promote transient chromatin disorganization and his-
tone reshaping in response to DNA damage (8). Because SET/
TAF-Iβ belongs to the NAP1 family, it is tempting to hypothesize
a role—similar to that described for the above-mentioned histone
chaperones—for SET/TAF-Iβ in chromatin reshaping in response
to DNA lesions. Such a role would also explain the Cc-mediated
inhibition observed here.The results of ITC and NMR titrations
herein performed reveal the oncoprotein SET/TAF-Iβ as binding
specifically to Cc. Interestingly, Cc uses the surface residues sur-
rounding its heme group to interact with the histone chaperone, as
it does with its respiratory partners cytochrome c oxidase (28) and
cytochrome bc1 (29) and its apoptotic partner Apaf-1 (31). Muta-
genesis and NMR-based docking analysis carried out here dem-
onstrated that Cc docks between the two histone-binding domains
Fig. 4. Proposed model of Cc-mediated nucleosome assembly disability
under DNA damage. Schematic assembly of nucleosomes by SET/TAF-Iβ under
homeostasis (Upper) and its impairment by Cc upon nuclear translocation
under DNA damage conditions (Lower), both showing mitochondrial outer
membrane (MOM), mitochondrial intermembrane space (IMS), mitochondrial
inner membrane (MIM), and matrix (MM).
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of SET/TAF-Iβ, thereby preventing the binding of the latter to core
histones. Therefore, and as inferred from nucleosome assembly
activity assays, it may be concluded that Cc not only binds to SET/
TAF-Iβ, but also hampers the latter’s histone chaperone activity. It
may therefore be proposed that, following DNA damage, the
translocation of Cc into the cell nucleus and resulting core histone
displacement may hinder SET/TAF-Iβ nucleosome assembly ac-
tivity (Fig. 4). Thus, the specific inhibition of SET/TAF-Iβ by Cc
could contribute not only to suppressing the former’s normal
chaperone activity when apoptosis is inevitable and such activity
is no longer necessary, but also to obstructing the nucleosome
remodelling that follows DNA damage repair. It has been proposed
that mitochondria from apoptotic cells are capable of oxidizing
cytosolic Cc via cytochrome c oxidase and that this oxidized form
induces caspase activation (38). Later, cytosolic Cc can be reduced
by several reductants, leading to diminished caspase activation.
Moreover, it is known that nuclei have reduced redox potentials,
but are relatively resistant to oxidation (39). Our results suggest that
the redox state of Cc does not influence its binding to its nuclear
target SET/TAF-Iβ. Our finding that Cc interacts with the onco-
protein SET/TAF-Iβ upon its release from mitochondria suggests
that the role of Cc in the execution of apoptosis is wider than
previously held, insofar as it goes beyond caspase cascade ac-
tivation, by also inhibiting prosurvival Cc partners. To our
knowledge, this is the first time that a specific role for nuclear
Cc has been suggested. The results presented not only reveal
the molecular basis for the blocking of SET/TAF-Iβ activity by
Cc, but also suggest that the inhibition of this oncoprotein
could be a promising objective in the development of antican-
cer drugs. More specifically, an understanding of the molecular
interfaces in the complex formed by SET/TAF-Iβ and its in-
hibitor, Cc, could facilitate the development of new drugs
aimed at silencing the oncogenic effect of SET/TAF-Iβ histone
chaperone activity.
Materials and Methods
The expression and purification of Cc, wild-type SET/TAF-Iβ, and its mutants
and histones are described in SI Appendix, as are other experimental con-
ditions and calculations.
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